In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Cardiac-oncology (C-O) services : rationale, organization and implementation
Session

Event : EuroEcho 2018

Topic : Imaging: Myocardial Disease

  • Session type : Clinical Seminar
  • Date : 06 December 2018
  • Time : 14:00 - 15:30

4 presentations in this session

The starting point: ESC position paper on cardiovascular toxicity in cancer patients.

Event : EuroEcho 2018

  • Session : Cardiac-oncology (C-O) services : rationale, organization and implementation
  • Speaker : T Lopez Fernandez (Madrid,ES)

Why we need a C-O Services: the background.

Event : EuroEcho 2018

  • Session : Cardiac-oncology (C-O) services : rationale, organization and implementation
  • Speaker : T Suter (Bern,CH)

Objectives of C-O Services in the clinical practice.

Event : EuroEcho 2018

  • Session : Cardiac-oncology (C-O) services : rationale, organization and implementation
  • Speaker : P Lancellotti (Liege,BE)

Role of cariac imaging in C-O services - present and furture outlook.

Event : EuroEcho 2018

  • Session : Cardiac-oncology (C-O) services : rationale, organization and implementation
  • Speaker : M Galderisi (Naples,IT)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are